orphenadrine has been researched along with Neurotic Disorders in 2 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VAN HERCK, J | 1 |
| VERSTER, JP | 1 |
2 other studies available for orphenadrine and Neurotic Disorders
| Article | Year |
|---|---|
[Clinical experiences with Disipal in a kinetic depressions and in obsessive neuroses].
Topics: Depression; Depressive Disorder; Humans; Neurotic Disorders; Obsessive-Compulsive Disorder; Orphenad | 1961 |
PRELIMINARY REPORT ON THE TREATMENT OF MENTALLY DISORDERED PATIENTS BY INTRATHECALLY ADMINISTERED PHENOTHIAZINE DRUGS AND AN ANTISEROTONIN SUBSTANCE.
Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Catatonia; Ergot Alkaloids; Injections, Spinal; Mental | 1963 |